Showing results (491-500 of 6,286) with videos related to
Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|February 28, 2001
Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic controlR F Santos, R Nomizo, E Oliveira, et al.Diabetes, Obesity & Metabolism|February 28, 2001
Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapyJ Saltevo, J Puolakka, O YlikorkalaDiabetes, Obesity & Metabolism|February 28, 2001
Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesityJ P Bastard, C Jardel, E Bruckert, et al.Diabetes, Obesity & Metabolism|March 13, 2003
Measurement of metformin concentration in erythrocytes: clinical implicationsJ-D Lalau, C LacroixDiabetes, Obesity & Metabolism|March 13, 2003
Differential effects of metformin on bile salt absorption from the jejunum and ileumD Carter, H C S Howlett, N F Wiernsperger, et al.Diabetes, Obesity & Metabolism|March 13, 2003
Detection of insulin resistance in Turkish adults: a hospital-based studyA Gokcel, M Baltali, E Tarim, et al.Diabetes, Obesity & Metabolism|March 13, 2003
Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterolG Valsamakis, R Chetty, P G McTernan, et al.Diabetes, Obesity & Metabolism|March 5, 2019
Decision models of prediabetes populations: A systematic reviewJose Leal, Liam Mc Morrow, Waqar Khurshid, et al.Diabetes, Obesity & Metabolism|March 5, 2019
Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetesGrégory Meiffren, Theresa Herbrand, Ernestos Anastassiadis, et al.Pageof 629